Resistance of hepatic RNA polymerases to compounds effecting RNA and protein synthesis in vivo  by Benecke, B.J. et al.
Volume 31, number 1 FEBS LETTERS April 1913 
RESISTANCE OF HEPATIC RNA POLYMERASES TO COMPOUNDS EFFECTING 
RNA AND PROTEIN SYNTHESIS IN WV0 
B.J.BENECKE,A.FERENCZ+ and K.H.SEIFART 
Institut ftir Physiologische Chemie, 355 Marburg/L, Lahnberge, B.R.D. 
Received 26 January 1973 
1. Introduction 
Alterations in RNA synthesis of eukaryotic cells, 
in particular that of the ribosomal precursor species, 
after cycloheximide [l-9] or hormone treatment 
[lo-211 have been described by several authors. In 
order to understand the molecular basis for these 
changes, it is very important to assess whether the 
amount of RNA polymerase is responsible for these 
variations, suggesting a regulatory function for the 
concentration of RNA polymerase in these systems. 
Recently it was reported that cycloheximide [22] 
and cortisol [23] administration gave rise to signifi- 
cant variations of hepatic RNA polymerase activity 
and/or level. We present data in this report demon- 
strating that cycloheximide or cortisol treatment in 
uivo has no significant effect on the amount of RNA 
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polymerase when isolated by the procedure described 
1241. 
2. Materials and methods 
[3H]UTP(13.6 Ci/mmole) and L-[14C] tyrosine 
(30 Ci/mmole) were obtained from the Radiochemi- 
cal Centre (Amersham), nucleoside triphosphates, 
creatine phosphate and creatine phosphokinase from 
Boehringer (Mannheim); DEAE-cellulose (DE 32; 1 
meq/g) from Whatman (London). Cortisol was a gift 
of Schering AC (Berlin), cycloheximide was pur- 
chased from Serva (Heidelberg). All other chemicals 
were reagent grade from Merck (Darmstadt). 
In the case of the cycloheximide experiments, 
groups of three male Wistar BR II rats (120-l 40 g) 
were injected intraperitoneally either with saline or 
cycloheximide (0.4 mg/lOO g body weight) at 0 time. 
At times varying from 5 min (only allowing resorption 
of the drug) to 4, 12 and 24 hr, a control group and 
Table 1 
Inhibition of hepatic protein biosynthesis by cycloheximide in viva. 
Group: Ro Co K4 c4 K12 Cl2 K24 c24 
Cycloheximide: - + _ + _ + - + 
Time* (hr): 0 0 4 4 12 12 24 24 
Protein (cpm/mg): 2105 2097 3338 431 2884 691 3365 2230 
Inhibition (%): 0.5 86.9 76.0 33.7 
* Animals were killed at the indicated times after intraperitoneal injection of the drug (400 rg/lOO g body weight). 0 hr implies 
that rats were sacrificed after 5 min, only allowing resorption of the inhibitor. Protein was determined by the Lowry method. 
Radioactivity was determined in the ultracentrifuged cytoplasmic fraction by precipitation with 1 .l M trichloroacetic acid. Pel- 
lets were rewashed 3 times with 12% TCA, 2 times with methanol, dissolved in formic acid, and counted in 15 ml Bray’s solu- 
tion [25]. 
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Fig. 1, Simultaneous chromatography of nuclear RNA polymerase activities from control (A --A --A) and cycloheximide treated 
(O-O-O) animals on identical 2.5 x 5 cm DEAE-cellulose columns. Elution of approx. 3.5 ml fractions was achieved with a lin- 
ear gradient from 0.0 to 0.35 M NH&l in buffer (T&Cl, 0.05 M, pH 7.9, 20% glycerol, 5 mM mercaptoethanol, 0.25 mM EDTA) 
pumped from an ultrograd mixer at a flow rate of 40 ml/hr. In order to achieve identical conditions all columns were packed from 
the same batch of exchanger and were developed in pairs at identical elution rates from one pump (with multiple outlets) from the 
same elution medium. 
a cycloheximide treated group were killed simulta- 
neously. One animal of each control and inhibitor 
treated group received L- [ 14C] tyrosine intraperitone- 
ally (22 Ki/ 100 g body weight) 30 min before sacri- 
fice, thus monitoring the extent of protein bio-synthe- 
sis as outlined in table 1. In the hormone trials, rats 
were adrenalectomized 3 days prior to the experiment. 
Two groups of eight animals were each injected intra- 
peritoneally with saline or cortisol(3 me! 100 g body 
weight) 3 hr before sacrifice. Nuclear RNA polymer- 
ases A and B and cytoplasmic RNA polymerase C 
were extracted from the liver and measured in vitro 
as described by Seifart et al. [24] . 
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Fig. 2. Simultaneous chromatography of the cytosol from control (A--A--A) and cycloheximide treated (0-o-o) animals on 
identical 2.5 X 5 cm DEAE-cellulose columns. Conditions were as described in fig. 1. In this case the developing gradient was from 
0.0 to 0.60 M NH&l. 
3. Results 
3.1. Effect of cycloheximide on RNA polymerase 
activity 
In order to obtain an estimate of the half-life of 
hepatic RNA polymerase species from rat liver, cyclo- 
heximide was administered in vivo for several time pe- 
riods ranging from 5 min to 24 hr. All steps of extrac- 
tion and particularly purification of the enzymes 
from inhibitor-treated and the corresponding control 
groups were conducted simultaneously under identi- 
cal conditions, as described in fig. 1, thus ensuring 
that the corresponding curves of enzyme activities are 
directly comparable. 
Fig. 1 depicts the profiles obtained upon DEAE- 
cellulose chromatography of nuclear RNA polymerase 
activities A and B extracted after the indicated times 
of cycloheximide injection. The values in the figures 
represent absolute activities expressed as counts per 
minute. Correction for protein content has deliberate- 
ly not been undertaken since protein concentrations 
could vary as a function of cycloheximide treatment 
and a correction for this variable could then possibly 
eliminate an effect which the experiment was de- 
signed to measure. However, extreme care was taken 
to equalize experimental conditions as outlined, thus 
allowing a direct comparison of individual column 
profiles. 
When comparing RNA polymerase activities of con- 
trol and cycloheximide treated animals, no marked 
difference can be detected for either nuclear enzyme 
A or B. This applies even to the longest times of cyclo- 
heximide application and to the ratio of the two en- 
zymes A/B within any one column. The apparent ac- 
tivity of the A enzyme is lower in all cases which is a 
function of the assay conditions (Mn2+; (NH&SO,; 
heat denatured DNA) favouring enzyme B. Differ- 
ences which do occur between treatment-groups do 
not follow the time of cycloheximide application and 
could be attributed to experimental error. 
The results obtained for the enzyme extracted 
from the cytoplasm (fig. 2) likewise convey the con- 
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Fig. 3. Simultaneous chromatography on identical 2.6 X 13 cm DEAE-cellulose columns of RNA polymerase activities isolated 
from nuclei (part A) or cytoplasm (part B) from adrenalectomized animals treated with saline (control A--A--A) or cortisol 
(O-O-O). Conditions were as described in fig. 1 and 2. 
elusion, that there is no significant decrease in enzyme 
activity during a 24 hr period after cycloheximide 
treatment, 
Table 1 shows the degree of inhibition of overall 
protein synthesis measured concomitantly by 
[14C] tyrosine incorporation as described in Methods. 
It clearly shows a drastic inhibition of protein synthe- 
sis (’ 86%) 4 hr after administration of the drug which 
was still 76% after 12 hr. At 24 hr protein biosynthe- 
sis was restored to 66% which was also reflected in a 
recovery of the general health condition of the ani- 
mals. It was not attempted to achieve complete inhibi- 
tion of protein synthesis, since pilot experiments had 
demonstrated that higher dosages of cycloheximide 
totally suppressing amino acid incorporation (8 mg/ 100 
g body weight) killed all the animals within 6 hr, thus 
preventing an assessment of slowly turning over pro- 
teins. 
3.2. Effect of cortisol on RlvA polymerase activity 
Fig. 3 represents the profile on DEAE-cellulose of 
RNA polymerase isolated from nuclei (part A) or 
cytoplasm (part B) from adrenalectomized animals 
treated with saline (controls) or cortisol. The columns 
containing the nuclear extract were extensively 
washed with buffer into individual fractions as indi- 
cated in fig. 3, in order to detect a polymerase species 
designated as 1 A by Sajdel et al. [23] and also re- 
ported by Schmuckler et al. [20]. Our data show only 
two RNA polymerase activities eluting from this col- 
umn at 0.19 M and 0.30 M NH,CI, corresponding to 
RNA polymerase A and B [26,24] . Apart from 
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insignificantly lower values for the control curve re- 
lated to a lower protein concentration, there is no 
marked difference between treatment-groups. Virtual- 
ly the same results are obtained if polymerase C is iso- 
lated from either adrenalectomized or hormone 
treated animals and analyzed on DEAE-cellulose col- 
umns (fig. 3B). 
4. Discussion 
The data presented here lead to the conclusion 
that the amount of nuclear RNA polymerase A and 
B, as well as of cytoplasmic enzyme C isolated from 
rat liver tissue by the technique described [24], re- 
main unaltered after a 24 hr treatment period of 
cycloheximide or 3 hr application of cortisol in viva 
These findings are in disagreement with results reported 
by Yu and Feigelson [22] who found a rapid decrease 
of nucleolar RNA polymerase activity in rat liver after 
cycloheximide application, measured as UTP incorpo- 
ration of intact nucleoli under certain experimental 
conditions. These workers concluded from their find- 
ings that polymerase A has a rapid turnover time and 
that control of RNA synthesis, in particular of ribo- 
somal RNA, can effectively be achieved by a variation 
in the amount of enzyme synthesized. This assump- 
tion would be reconcilable with experiments stating 
an enhanced amount of nucleolar RNA polymerase 
after hormone treatment [20,23,27] . This conclu- 
sion is, however, not supported by data presented 
here and results of Sekeris and coworkers [21,28]. 
All the RNA polymerase species from rat liver stu- 
died here seem to be unaffected by conditions which 
lead to a strong inhibition of protein synthesis for at 
least 12 hr. It is also interesting to note, that at a time 
when general protein synthesis is in the recovery 
phase (24 hr; table l), there is no drastic change in 
the amount of RNA polymerase, in the sense of a re- 
bound effect. Therefore the enzyme molecules seem 
to have extended half life periods, representing a fair- 
ly stable population. Among others, one of the aims 
of these experiments was to possibly determine the 
biosynthetic interrelationships between enzymes A, B 
and particularly C. It is questionable however, whether 
this approach is feasible with proteins of very long 
half-life values. The conclusions drawn from these ex- 
periments are valid under the assumption that the in- 
hibition of protein synthesis by cycloheximide is ran- 
dom for all proteins and that the level of residual pro- 
tein synthesis (* 10%) required to keep the animals 
alive for periods over 6 hr, does not account for com- 
pletely normal synthesis of RNA polymerase. No such 
selective mechanism of escape-synthesis after cyclo- 
heximide has been described, however, and experi- 
ments conducted with 3.0 mg cycloheximide/ 100 g for 
4hr showed a complete blockade of peptide synthesis 
but maintained enzyme levels exceeding 85% of the 
control values. 
The remarkable inertia of the RNA synthesizing en- 
zyme must be viewed in the light of the well docu- 
mented inhibition of RNA synthesis by cycloheximide 
[l-9] . It is therefore rather difficult to assume that 
the rate of RNA synthesis can be controlled through 
enzyme concentrations. In contrast, the situation 
seems to apply that RNA polymerase may be present 
in large excess, and the presence of a cytoplasmic en- 
zyme [24] could be an expression of this abundance. 
Recent calculations by Chambon [29] show an aver- 
age number of 3.9 X lo4 polymerase B molecules per 
haploid genome, containing a tentative number of 
50,000 promotor sites. If it is assumed that only a por- 
tion of these are active in native chromatin, these cal- 
culations would support the conclusion concerning 
the relative abundance of the RNA polymerase mole- 
cule in relation to the number of specific initiation 
points of RNA synthesis. Therefore regulation of 
RNA synthesis in the eukaryotic nucleus is possibly 
achieved through other factors controlling the rate of 
this process. It is possible that the multiple forms of 
RNA polymerase recognize specific and different pro- 
motor sites (30,311 . This question is, however, re- 
lated to specificity and not rate of RNA synthesis. 
It is also of importance to note, that synthesis of 
ribosomal and of heterogeneous nuclear RNA are pos- 
sibly interrelated as has recently been concluded by 
Schmid and Sekeris [32]. It is possible that shortlived 
proteins, as have been postulated by Muramatsu [7] 
which could be synthesized on short-lived RNA mes- 
sages, function as such specifiers of RNA synthesis. 
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